Statistics for MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2
Total visits
| views | |
|---|---|
| MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2 | 292 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| oncotarget-07-53254.pdf | 222 |
| java.util.UUID:80b90d2b-f136-496e-b494-eeff6f4d7311 | 62 |
| java.util.UUID:2b5b8348-2e60-4266-99ae-6d34c0c70b80 | 5 |
| java.util.UUID:2d3f7efc-0bbd-4460-9497-56dd649662eb | 2 |
Top country views
| views | |
|---|---|
| United States | 226 |
| Germany | 15 |
| Ukraine | 6 |
| Austria | 5 |
| China | 3 |
| United Kingdom | 3 |
| Russia | 3 |
| Canada | 2 |
| France | 1 |
| Italy | 1 |
| Malaysia | 1 |
Top city views
| views | |
|---|---|
| Wilmington | 52 |
| Ann Arbor | 43 |
| Fairfield | 28 |
| Houston | 20 |
| Kiez | 13 |
| White Plains | 11 |
| Jacksonville | 7 |
| Falls Church | 6 |
| Kiev | 6 |
| Vienna | 5 |
| Seattle | 4 |
| Saint Petersburg | 3 |
| Abingdon | 2 |
| Brooklyn | 2 |
| Cambridge | 2 |
| Concord | 2 |
| Gunzenhausen | 2 |
| San Francisco | 2 |
| Toronto | 2 |
| Washington | 2 |
| Augusta | 1 |
| Baltimore | 1 |
| Beijing | 1 |
| Irvine | 1 |
| Milan | 1 |
| Overland Park | 1 |
| Philadelphia | 1 |
| Roubaix | 1 |
| Scottsdale | 1 |
| Seremban | 1 |
| Shenzhen | 1 |
| Tustin | 1 |